Human papillomavirus (HPV) vaccine hesitancy trends in the United States.
Publication
, Conference
Boakye, EA; Abouelella, DK; Nair, M; Osazuwa-Peters, N
Published in: JOURNAL OF CLINICAL ONCOLOGY
2022
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2022
Volume
40
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Boakye, E. A., Abouelella, D. K., Nair, M., & Osazuwa-Peters, N. (2022). Human papillomavirus (HPV) vaccine hesitancy trends in the United States. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).
Boakye, Eric Adjei, Dina K. Abouelella, Mrudula Nair, and Nosayaba Osazuwa-Peters. “Human papillomavirus (HPV) vaccine hesitancy trends in the United States.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.
Boakye EA, Abouelella DK, Nair M, Osazuwa-Peters N. Human papillomavirus (HPV) vaccine hesitancy trends in the United States. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.
Boakye, Eric Adjei, et al. “Human papillomavirus (HPV) vaccine hesitancy trends in the United States.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.
Boakye EA, Abouelella DK, Nair M, Osazuwa-Peters N. Human papillomavirus (HPV) vaccine hesitancy trends in the United States. JOURNAL OF CLINICAL ONCOLOGY. 2022.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2022
Volume
40
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences